𝔖 Bobbio Scriptorium

✦ LIBER ✦

FP58-FR-04 Clinical profile of the novel oral CGRP receptor antagonist telcagepant for the acute treatment of migraine in phase 3 studies

✍ Scribed by T.W Ho

Book ID: 119467926
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 61 KB
Volume: 285
Category: Article
ISSN: 0022-510X
DOI: 10.1016/s0022-510x(09)70578-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of Human Calcitonin Gene-Rel

Development of Human Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists. 1. Potent and Selective Small Molecule CGRP Antagonists. 1-[ N 2 -[3,5-Dibromo- N -[[4-(3,4-dihydro-2(1 H )-oxoquinazolin-3-yl)-1- piperidinyl]carbonyl]- d -tyrosyl]- l -lysyl]-4-(4-pyridinyl)piperazine: The First CGRP Antagonist for Clinical Trials in Acute Migraine †

✍ Rudolf, Klaus; Eberlein, Wolfgang; Engel, Wolfhard; Pieper, Helmut; Entzeroth, M 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 222 KB